Salbutamol Research Overview
Salbutamol is a beta-2 adrenergic receptor agonist extensively studied for its bronchodilatory properties in respiratory research. This GlaxoSmithKline compound represents a selective short-acting beta-agonist (SABA) that demonstrates high affinity for beta-2 adrenergic receptors in pulmonary tissue models. Laboratory investigations examine its mechanism of action through cyclic adenosine monophosphate (cAMP) pathway activation, leading to smooth muscle relaxation in bronchial tissue preparations. Research applications focus on understanding beta-adrenergic signalling cascades and their role in respiratory physiology.
At Stroid UK Shop, researchers studying respiratory pharmacology can access this pharmaceutical-grade compound for controlled investigations. Studies evaluate salbutamol’s selectivity profile compared to other adrenergic agonists, examining its preferential binding to beta-2 over beta-1 receptors in cardiac tissue models. The compound’s rapid onset and short duration of action make it valuable for acute bronchospasm research protocols. Investigators examine metabolic pathways, including hepatic conjugation and renal elimination processes in pharmacokinetic studies.
Research Applications and Mechanisms
Laboratory studies investigate salbutamol’s molecular interactions with beta-2 adrenergic receptors using binding assays and functional analyses. Researchers examine its effects on intracellular calcium mobilisation and protein kinase A activation in smooth muscle cell cultures. Comparative studies evaluate its potency against other beta-agonists in isolated tissue preparations. The compound’s stereochemistry research focuses on R-salbutamol’s enhanced selectivity compared to racemic formulations. Investigations include dose-response relationships in various tissue models and species-specific receptor binding characteristics.
Advanced research protocols examine salbutamol’s anti-inflammatory properties beyond bronchodilation, including mast cell stabilisation and cytokine modulation studies. Our salbutamol research section provides compounds alongside other respiratory modulators for comprehensive studies. Researchers also explore its potential cardioprotective mechanisms and metabolic effects in cellular energy metabolism investigations. Cross-referencing with SARMS research and peptide studies enables broader pharmacological comparisons in multi-target research programmes.
Product Specifications
| Parameter | Value |
|---|---|
| Molecular Formula | C₁₃H₂₁NO₃ |
| Molecular Weight | 239.31 g/mol |
| CAS Number | 18559-94-9 |
| Manufacturer | GlaxoSmithKline |
| Purity | Pharmaceutical grade |
| Storage | Room temperature, dry environment |
Research Compliance Statement
This salbutamol research compound is supplied exclusively for in-vitro laboratory research purposes. Not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with institutional guidelines and regulatory requirements for beta-agonist compound handling and storage protocols.
